The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
β-Blocker Use, BMD, and Fractures in the Study of Osteoporotic Fractures
Open accessAbstract
A role for osteoblastic β-adrenoreceptors in bone regulation is suggested by the finding that β-blockers increase bone mass in mice. We studied the association of β-blocker use with BMD and fractures in the Study of Osteoporotic Fractures. β-blocker use and BMD are unrelated in this cohort, and associations with fracture risk are inconsistent. Introduction: The central nervous system has been shown to regulate bone mass in mice, possibly by way of the β2-adrenoreceptors on osteoblasts. β-blockers have been shown to increase bone mass in mice. Because these agents are widely used therapeutically, it is possible that they may influence fracture epidemiology in humans, and they are a potential therapy for osteoporosis. Materials and Methods: We have studied the association of β-blocker use with BMD and fracture rates in the Study of Osteoporotic Fractures. β-blocker use was recorded at the fourth visit, in 8412 women, of whom 1099 were users, and these women were followed for 7 years. Results: Users had significantly higher weight, more thiazide use, more estrogen use, less glucocorticoid use, more statin use, and more hypertension than nonusers, and they smoked less. Total hip BMD at the fourth visit was higher in the β-blocker users (0.746 versus 0.735 g/cm2, p = 0.02), but adjustment for weight alone, or together with these other variables, eliminated this difference (p = 0.62). There was no effect of β-blocker use on loss of hip BMD over a mean follow-up of 4 years (p = 0.48). Os calcis BMD at visit 4 was also higher in those taking β-blockers (0.385 versus 0.375 g/cm2, p = 0.005), but weight adjustment eliminated this difference (p = 0.14). The frequencies of hip or any fracture (since age 50) were similar in users and nonusers (p = 0.80 and p = 0.51, respectively). Over a mean follow-up of 7 years, there were 2167 total fractures, including 431 at the wrist and 585 at the hip. Among β-blocker users, hazards ratios were 0.92 (0.81, 1.05) for any fracture, 0.74 (0.54, 1.01) for wrist fracture, and 0.76 (0.58, 0.99) for hip fracture. Adjustment for weight and other factors previously shown to influence hip fracture incidence in this cohort made little difference to the outcome. When fracture data were analyzed for nonselective and β1-selective agents separately, trends toward fewer fractures were confined to the users of selective β1-blockers. Conclusions: β-blocker use and BMD are unrelated in this cohort, and associations with fracture risk are inconsistent. Therefore, a history of use of these drugs is not useful in assessing fracture risk, nor do they have a role in osteoporosis management at this time. The relationship between β-blocker use and hip fracture deserves further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Leptin deficiency or resistance is associated with high BMD in mice despite the fact that gonadal function is diminished (103).”
From Pathogenesis of osteoporosis: concepts, conflicts, and prospects (2005) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leptin Inhibits Bone Formation through a Hypothalamic Relay
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., & Karsenty, G. (2000) · Cell · doi:10.1016/s0092-8674(00)81558-5 · Cited by 2,077
Leptin Regulates Bone Formation via the Sympathetic Nervous System
Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., & Karsenty, G. (2002) · Cell · doi:10.1016/s0092-8674(02)01049-8 · Cited by 1,735
Cauley, J. A. (2003) · JAMA · doi:10.1001/jama.290.13.1729 · Cited by 1,229
Pasco, J. A., Henry, M. J., Sanders, K. M., Kotowicz, M. A., Seeman, E., & Nicholson, G. C. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301214 · Cited by 260
Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats
Hill, E. L., Turner, R. T., & Elde, R. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90094-5 · Cited by 187
Reid, I. R., Ames, R. W., Orr‐Walker, B., Clearwater, J. M., Horne, A. M., Evans, M. C., Murray, M. A. F., McNeil, A. R., & Gamble, G. D. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00510-6 · Cited by 179
Self-citationMoore, R. E. B., Smith, C. K., Bailey, C. S., Voelkel, E. F., & Tashjian, A. H. (1993) · Bone and Mineral · doi:10.1016/s0169-6009(08)80105-5 · Cited by 175
Cherruau, M., Facchinetti, P., Baroukh, B., & Jl, S. (1999) · Bone · doi:10.1016/s8756-3282(99)00211-2 · Cited by 144
Takeuchi, T., Tsuboi, T., Arai, M., & Togari, A. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00591-8 · Cited by 139
Intermittent Use of Nitrates Increases Bone Mineral Density: The Study of Osteoporotic Fractures
Jamal, S. A., Browner, W. S., Bauer, D. C., & Cummings, S. R. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.11.1755 · Cited by 131
Self-citation
Cited by
Sorted by citations
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779
Relationships between fat and bone
Reid, I. R. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0492-z · Cited by 475
Self-citationReid, I. R. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.06.027 · Cited by 368
Self-citationImpact of the Autonomic Nervous System on the Skeleton
Elefteriou, F. (2018) · Physiological Reviews · doi:10.1152/physrev.00014.2017 · Cited by 248
A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms
Confavreux, C. B., Levine, R. L., & Karsenty, G. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.04.004 · Cited by 246
Regulation of bone remodeling by the central and peripheral nervous system
Elefteriou, F. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.016 · Cited by 229
Leptin and the sympathetic connection of fat to bone
Hamrick, M. W., & Ferrari, S. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0487-9 · Cited by 223
Effects of Leptin on the Skeleton
Reid, I. R., Baldock, P. A., & Cornish, J. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00226 · Cited by 215
Self-citationThe skeleton as an endocrine organ
DiGirolamo, D. J., Clemens, T. L., & Kousteni, S. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.157 · Cited by 183
Wiens, M. O., Etminan, M., Gill, S. S., & Takkouche, B. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01695.x · Cited by 173
Control of Bone Remodeling by the Peripheral Sympathetic Nervous System
Elefteriou, F., Campbell, P. J., & Ma, Y. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9752-4 · Cited by 169
Lynn, H., Kwok, T. C. Y., Wong, S. Y. S., Woo, J., & Leung, P. (2005) · Bone · doi:10.1016/j.bone.2005.09.011 · Cited by 143
Bonnet, N., Gadois, C., McCloskey, E. V., Lemineur, G., Lespessailles, É., Courteix, D., & Benhamou, C. L. (2007) · Bone · doi:10.1016/j.bone.2007.01.006 · Cited by 143
Clinical Risk Factors for Fractures in Multi-Ethnic Women: The Women's Health Initiative
Cauley, J. A., Wu, L., Wampler, N. S., Barnhart, J., Allison, M., Chen, Z., Jackson, R. D., & Robbins, J. A. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070713 · Cited by 138
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling
Baker, J. G., Hill, S. J., & Summers, R. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.02.010 · Cited by 134
Neuronal signaling and the regulation of bone remodeling
Elefteriou, F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5175-3 · Cited by 131
Osteoblastogenesis regulation signals in bone remodeling
Zuo, C., Huang, Y., Bajis, R., Sahih, M., Li, Y., Dai, K., & Zhang, X. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1909-x · Cited by 129
Risk of fractures in older adults using antihypertensive medications
Solomon, D. H., Mogun, H., Garneau, K., & Fischer, M. A. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.356 · Cited by 121
Bone: from a reservoir of minerals to a regulator of energy metabolism
Confavreux, C. B. (2011) · Kidney International · doi:10.1038/ki.2011.25 · Cited by 113
Reid, I. R., Lucas, J., Wattie, D. J., Horne, A. M., Bolland, M. J., Gamble, G. D., Davidson, J. S., & Grey, A. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0573 · Cited by 112
Self-citationDose Effects of Propranolol on Cancellous and Cortical Bone in Ovariectomized Adult Rats
Bonnet, N., Laroche, N., Vico, L., Dolleans, E., Benhamou, C. L., & Courteix, D. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.105437 · Cited by 109
Ilić, K., Obradović, N., & Vujasinović-Stupar, N. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9671-9 · Cited by 104
Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
Bonnet, N., Pierroz, D. D., & Ferrari, S. (2008) · PubMed · Cited by 101
Bonnet, N., Benhamou, C. L., Malaval, L., Gonçalves, C., Vico, L., Eder, V., Pichon, C., & Courteix, D. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21564 · Cited by 99
Aitken, S. J., Landao‐Bassonga, E., Ralston, S. H., & Idris, A. I. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.11.012 · Cited by 99
The role of the sympathetic nervous system in controlling bone metabolism
Togari, A., Arai, M., & Kondo, A. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.931 · Cited by 88
Levasseur, R., Dargent‐Molina, P., Sabatier, J., Marcelli, C., & Bréart, G. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53178_7.x · Cited by 85
Togari, A., & Arai, M. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fm0070227 · Cited by 81
Wu, X., Al‐Abedalla, K., Eimar, H. A., Madathil, S. A., Abi‐Nader, S., Daniel, N. G., Nicolau, B. F., & Tamimi, F. (2016) · Clinical Implant Dentistry and Related Research · doi:10.1111/cid.12414 · Cited by 79
Bouxsein, M., Devlin, M. J., Glatt, V., Dhillon, H., Pierroz, D. D., & Ferrari, S. (2009) · PubMed · doi:10.1210/en.2008-0843 · Cited by 76
Use of β-Blockers and the Risk of Hip/Femur Fracture in the United Kingdom and The Netherlands
de Vries, F., Souverein, P. C., Cooper, C. C., Leufkens, H. G. M., & van Staa, T. P. (2007) · Calcified Tissue International · doi:10.1007/s00223-006-0213-1 · Cited by 76
Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine)
Warden, S. J., Bliziotes, M. M., Wiren, K. M., Eshleman, A. J., & Turner, C. H. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.06.005 · Cited by 77
Sympathetic Nervous System Does Not Mediate the Load-Induced Cortical New Bone Formation
de Souza, R. L., Pitsillides, A. A., Lanyon, L. E., Skerry, T. M., & Chenu, C. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050812 · Cited by 75
Margolis, K. L., Palermo, L., Vittinghoff, E., Evans, G. W., Atkinson, H. H., Hamilton, B. P., Josse, R. G., O’Connor, P. J., Simmons, D. L., Tiktin, M., et al. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2961-3 · Cited by 75
Toulis, K. A., Hemming, K., Stergianos, S., Nirantharakumar, K., & Bilezikian, J. P. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2498-z · Cited by 74
Puttnam, R., Davis, B. R., Pressel, S., Whelton, P. K., Cushman, W. C., Louis, G. T., Margolis, K. L., Oparil, S., Williams, J. S., Ghosh, A., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.6821 · Cited by 69
Pierroz, D. D., Bouxsein, M., Rizzoli, R., & Ferrari, S. (2006) · Bone · doi:10.1016/j.bone.2006.01.145 · Cited by 67
Fonseca, T. L., Jorgetti, V., Costa, C. C., Capelo, L. P., Covarrubias, A. E., Moulatlet, A. C. B., Teixeira, M. B. C. G., Hesse, E., Morethson, P., Beber, E. H., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.243 · Cited by 66
Graham, S. M., Hammond-Jones, D., Gamie, Z., Polyzois, I., Tsiridis, E., & Tsiridis, E. E. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.9.1281 · Cited by 65
Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study
Ruths, S., Bakken, M. S., Ranhoff, A. H., Hunskaar, S., Engesaeter, L. B., & Engeland, A. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0154-5 · Cited by 65
Ji-ye, H., Jiang, L., & Dai, L. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.01.002 · Cited by 66
Use of beta‐2 agonists and risk of hip/femur fracture: a population‐based case‐control study
de Vries, F., Pouwels, S., Bracke, M., Leufkens, H. G. M., Cooper, C. C., Lammers, J. J., & van Staa, T. P. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1318 · Cited by 63
Regulation of glucose metabolism and the skeleton
Ng, K. W. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04133.x · Cited by 58
Blockade of beta-adrenergic signaling does not influence the bone mechano-adaptive response in mice
Marenzana, M., de Souza, R. L., & Chenu, C. (2007) · Bone · doi:10.1016/j.bone.2007.04.184 · Cited by 59
Meisinger, C., Heier, M., Lang, O., & Döring, A. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0354-8 · Cited by 59
Mundy, G. R., Oyajobi, B. O., Gutierrez, G. E., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50020-3 · Cited by 59
β1 selectivity of β-blockers and reduced risk of fractures in elderly hypertension patients
Song, H. J., Lee, J., Kim, Y.-J., Jung, S., Kim, H. J., Choi, N., & Park, B. (2012) · Bone · doi:10.1016/j.bone.2012.08.126 · Cited by 57
Co-dependence of bone and energy metabolisms
Wei, J., & Ducy, P. F. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.021 · Cited by 57
Inner Ear Vestibular Signals Regulate Bone Remodeling via the Sympathetic Nervous System
Vignaux, G., Ndong, J. D. L. C., Perrien, D. S., & Elefteriou, F. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2426 · Cited by 50
Association between beta-blockers and fracture risk: A Bayesian meta-analysis
Yang, S., Nguyen, N. D., Eisman, J. A., & Nguyen, T. V. (2012) · Bone · doi:10.1016/j.bone.2012.07.013 · Cited by 44
Inoue, D., Muraoka, R., Okazaki, R., Nishizawà, Y., & Sugimoto, T. (2015) · Calcified Tissue International · doi:10.1007/s00223-015-0071-9 · Cited by 41
The Effects of Antihypertensive Drugs on Bone Mineral Density in Ovariectomized Mice
Kang, K. Y., Kang, Y., Kim, M., Kim, Y., Yi, H., Kim, J., Jung, H.-R., Park, S., Kim, H., Ju, J. H., et al. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.8.1139 · Cited by 41
Risk of fractures in subjects with antihypertensive medications: A nationwide claim study
Choi, H. J., Park, C. M., Lee, Y., Ha, Y., Jang, S., & Shin, C. S. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.072 · Cited by 39
The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk
Barzilay, J. I., Davis, B. R., Pressel, S., Ghosh, A., Puttnam, R., Margolis, K. L., & Whelton, P. K. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0888-0 · Cited by 39
The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese
Zhang, Y., Qin, L., Leung, P., & Kwok, T. C. Y. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0363-3 · Cited by 38
Anabolic Agents and the Bone Morphogenetic Protein Pathway
Garrett, I. R. (2007) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)78004-8 · Cited by 35
Neuronal Regulation of Aortic Valve Cusps
El-Hamamsy, I., Yacoub, M. H., & Chester, A. H. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109787354088 · Cited by 35
Cortical bone is an extraneuronal site of norepinephrine uptake in adult mice
Zhu, Y., Ma, Y., & Elefteriou, F. (2018) · Bone Reports · doi:10.1016/j.bonr.2018.11.002 · Cited by 34
Solomon, D. H., Ruppert, K. M., Zhao, Z., Lian, Y. J., Kuo, I.-H., Greendale, G. A., & Finkelstein, J. S. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3332-6 · Cited by 33
Ang, H. T., Lim, K. K., Kwan, Y. H., Tan, P. S., Yap, K. Z., Banu, Z., Tan, C. S., Fong, W. W. S., Thumboo, J., Østbye, T., et al. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0561-3 · Cited by 31
Effects of beta-blockers on fracture risk.
Reid, I. R. (2008) · PubMed · Cited by 30
Self-citationAssessment of bone mineral status in children with Marfan syndrome
Grover, M., Brunetti‐Pierri, N., Belmont, J. W., Phan, K., Tran, A. A., Shypailo, R. J., Ellis, K. J., & Lee, B. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35540 · Cited by 30
Central regulation of bone mass
Wong, I. P. L., Zengin, A., Herzog, H., & Baldock, P. A. J. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.08.001 · Cited by 30
Takarada, T., Hojo, H., Takarada‐Iemata, M., Sahara, K., Kodama, A., Nakamura, N., Hinoi, E., & Yoneda, Y. (2009) · Bone · doi:10.1016/j.bone.2009.05.004 · Cited by 27
Kremer, R. B., & Gilsanz, V. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00190 · Cited by 29
β-blockers reduce bone resorption marker in early postmenopausal women
Pasco, J. A., Henry, M. J., Nicholson, G. C., Schneider, H. G., & Kotowicz, M. A. (2005) · Annals of Human Biology · doi:10.1080/03014460500292168 · Cited by 26
Emerging pharmacologic therapies for osteoporosis
Grey, A. B. (2007) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.12.3.493 · Cited by 26
Self-citationSympathetic neural influence on bone metabolism in microgravity (Review)
Mano, T., Nishimura, N., & Iwase, S. (2010) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.97.2010.4.8 · Cited by 24
Strategies for the prevention and control of osteoporosis in developing countries
Morales‐Torres, J. (2006) · Clinical Rheumatology · doi:10.1007/s10067-006-0314-2 · Cited by 24
Vignaux, G., Besnard, S., Denise, P., & Elefteriou, F. (2015) · Current Osteoporosis Reports · doi:10.1007/s11914-015-0271-2 · Cited by 25
Sympathectomy alters bone architecture in adult growing rats
Pagani, F., Sibilia, V., Cavani, F., Ferretti, M., Bertoni, L., Palumbo, C., Lattuada, N., Luca, E. D., Rubinacci, A., & GUIDOBONO, F. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21775 · Cited by 23
A neuronal action of sirtuin 1 suppresses bone mass in young and aging mice
Luo, N., Mosialou, I., Capulli, M., Bisikirska, B. C., Lin, C., Huang, Y.-Y., Shyu, P. T., Guo, X.-D. E., Economides, A. N., Mann, J. J., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci152868 · Cited by 22
Effects of propranolol on the development of glucocorticoid-induced osteoporosis in male rats
Folwarczna, J., Pytlik, M., Śliwiński, L., Cegieła, U., Nowińska, B., & Rajda, M. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70620-x · Cited by 22
Alpha-adrenergic blocker mediated osteoblastic stem cell differentiation
Choi, Y. J., Lee, J., Lee, S. J., Chung, C., & Park, Y. J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.09.095 · Cited by 23
Autonomic control of bone formation
Ji-ye, H., Xin-Feng, Z., & Jiang, L. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00014-6 · Cited by 21
Sternberg, Z. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8481-2 · Cited by 20
Walsh, J., Newman, C., & Eastell, R. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.10.002 · Cited by 20
The neuro-osteogenic network: The sympathetic regulation of bone resorption
Togari, A., Arai, M., Kondo, H., Kodama, D., & Niwa, Y. (2012) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2011.12.002 · Cited by 20
Sympathetic nervous system and bone adaptive response to its mechanical environment.
Marenzana, M., & Chenu, C. (2008) · PubMed · Cited by 20
Macedo, F. A. F. F., Nunes, E. H. M., Vasconcelos, W. L., Santos, R. A. S., Sinisterra, R. D., & Cortés, M. E. (2012) · Cerâmica · doi:10.1590/s0366-69132012000400011 · Cited by 20
Sosa, M., Saavedra, P., de Tejada, M. J. G., Mosquera, J., Pérez-Cano, R., Olmos, J. M., Muñoz‐Torres, M., Amérigo, M. J., Moro, M. J., Díaz Curiel, M., et al. (2011) · Aging Clinical and Experimental Research · doi:10.1007/bf03654781 · Cited by 18
Chen, H., Ma, K., Hsieh, P., Liou, Y., & Jong, G. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.195472 · Cited by 17
Reid, I. R., & Richards, J. B. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9048-4 · Cited by 16
Self-citationIntroduction to Bone Development, Remodelling and Repair
Gruber, R., Pietschmann, P., & Peterlik, M. (2008) · Medical radiology · doi:10.1007/978-3-540-68604-0_1 · Cited by 16
Lary, C. W., Hinton, A. C., Nevola, K. T., Shireman, T. I., Motyl, K. J., Houseknecht, K. L., Lucas, F. L., Hallen, S. A. M., Zullo, A. R., Berry, S. D., et al. (2020) · JBMR Plus · doi:10.1002/jbm4.10388 · Cited by 16
Energy metabolism and the skeleton: Reciprocal interplay
Amelio, P. (2012) · World Journal of Orthopedics · doi:10.5312/wjo.v3.i11.190 · Cited by 15
miRNA Mechanisms Underlying the Association of Beta Blocker Use and Bone Mineral Density
Nevola, K. T., Kiel, D. P., Zullo, A. R., Weiß, S., Homuth, G., Foessl, I., Obermayer-Pietsch, B. M., Motyl, K. J., & Lary, C. W. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4160 · Cited by 13
Chen, X., Song, I., Dennis, J. E., & Greenfield, E. M. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070122 · Cited by 12
Bellasi, A., Zona, S., Orlando, G., Carli, F., Ligabue, G., Rochira, V., Santoro, A., Mussini, C., Guaraldi, G., & Raggi, P. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9767-x · Cited by 11
The osteoporosis revolution marches on
Raisz, L. G. (2007) · Journal of Orthopaedic Science · doi:10.1007/s00776-007-1133-2 · Cited by 13
A Systematic Review on the Relationship between β-blockers and Bone Health
Salari, P., & Abdollahi, M. R. (2010) · International Journal of Pharmacology · doi:10.3923/ijp.2010.577.583 · Cited by 10
Neuronal Regulation of Bone Remodeling
Elefteriou, F., & Karsenty, G. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch10 · Cited by 10
Hypertension and Dental Implants: A Systematic Review and Meta-Analysis
Hamadé, L., El-Disoki, S., & Chrcanovic, B. R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020499 · Cited by 14
Clonidine increases bone resorption in humans
Limonard, E. J., Schoenmaker, T., de Vries, T. J., Tanck, M. W. T., Heijboer, A. C., Endert, E., Fliers, E., Everts, V. E., & Bisschop, P. H. L. T. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3312-x · Cited by 9
Pérez‐Castrillón, J. L., Vega, G., Abad, L., Sanz, A., Mendo, M., García-Porrero, M., & Dueñas, A. (2007) · Joint Bone Spine · doi:10.1016/j.jbspin.2006.09.015 · Cited by 9
Pathophysiology of Osteoporosis
Raisz, L. G., Bilezikian, J. P., & Martin, T. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00082-3 · Cited by 11
Are beta-blockers useful in the prevention of osteoporotic fractures?
Pérez-Castrillón, J.-L., de Luis, D. A., & Duenas-Laita, A. (2009) · PubMed · Cited by 9
Kim, B., Lee, S. H., & Koh, J. (2019) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-019-9257-4 · Cited by 8
Miyasaka, N., Akiyoshi, M., & Kubota, T. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0534-x · Cited by 8
Central control of bone mass: potential therapeutic implications
Levasseur, R., Legrand, É., Chappard, D., & Audran, M. (2005) · Joint Bone Spine · doi:10.1016/j.jbspin.2005.10.002 · Cited by 8
Metadata
- Authors
- Reid, I. R., Gamble, G. D., Grey, A. B., Black, D. M., Ensrud, K. E., Browner, W. S., & Bauer, D. C.
- Affiliations
- University of Auckland (NZ)
- Department of Medicine, University of Auckland, Auckland, New Zealand
- University of California, San Francisco (US)
- University of Minnesota (US)
- Corresponding author
- Reid, Ian R
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-04-01
- Volume
- 20
- Issue
- 4
- Pages
- 613-618
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2046327104
- Cited by
- 156
- References
- 19
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 6 · 2018: 7 · 2017: 2 · 2016: 5 · 2015: 9 · 2014: 3 · 2013: 13 · 2012: 14
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Health Research Council of New Zealand
- National Institute on Aging (AG05394, AG-05407)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR035584, AR35583, AR-35584, AR 35582, R01AR035582, R01AR035583)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- beta-blockers, bone mineral density, osteoporotic fractures, hip fracture, wrist fractures, bone mass regulation, Study of Osteoporotic Fractures, women, thiazide diuretics, glucocorticoids, estrogen use, statins, hypertension, osteoporosis treatment, fracture risk factors
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Bone and Bones, Female, Fractures, Spontaneous, Humans, Osteoporosis, Bone Density, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
